What we do
Medicines New Zealand is the industry association representing pharmaceutical companies in New Zealand. Focused on improving access to innovative medicines and treatments, the organisation works to ensure New Zealanders benefit from the latest advancements in healthcare. Through partnerships with government, healthcare providers, and other stakeholders, Medicines New Zealand advocates for policies that enable timely access to high-quality medicines while promoting the value of innovation in improving patient outcomes. By engaging in research, education, and collaboration, the organisation supports a healthcare system that prioritises patient needs, clinical effectiveness, and sustainability.
Overview of our offering
- Advocacy for access: Promoting policies that ensure patients have timely access to innovative and life-changing medicines.
- Healthcare collaboration: Partnering with healthcare professionals, government agencies, and stakeholders to improve health outcomes across New Zealand.
- Promoting innovation: Highlighting the importance of research and development in advancing modern healthcare and bringing new treatments to market.
- Education and awareness: Providing education and resources to stakeholders on the value and role of medicines in improving patient care.
- Policy development: Supporting evidence-based policy initiatives that enhance healthcare delivery and access to treatments.
- Industry leadership: Representing pharmaceutical companies to ensure a balanced, collaborative, and patient-focused approach within the health sector.
Target customer: Healthcare providers, policymakers, pharmaceutical companies, and organisations seeking to improve patient outcomes through better access to innovative medicines.